Executive Director, Us Policy & Executive Branch Strategy
CurrentLead federal, state and therapeutic policy team responsible for policy development, analysis, communication and execution of regulations in a fast-paced corporate environment amid IRA negotiation, multiple product launches, and increased 340B activity. Received 2024 U.S. Commercialization Award.